Trigger
Contact us

Join our advanced solid tumor clinical trial

Have you been diagnosed with PIK3CA Mutant Clear Cell Ovarian, Endometrial, or Colorectal Cancer? You may be eligible to participate in our clinical study of Serabelisib in Combination with an Insulin Suppressing Diet.

 

Trial active but not enrolling as of January 2024.

 

Phase 2 trial in advanced endometrial cancer will begin enrollment in 2024.

 

Questions? Contact us, we're here to help!

We are committed to your fight, and to creating better cancer treatments for you and many others like you in the future.

Contact us